Inhaled corticosteroids and pneumonia risk - Revised knowledge.

P. Lange, J. Vestbo, J. Nyboe, Risk factors for death and hospitalization from pneumonia. A prospective study of a general population. European Respiratory Journal. ,vol. 8, pp. 1694- 1698 ,(1995) , 10.1183/09031936.95.08101694

D. M. G. Halpin, J. Gray, S. J. Edwards, J. Morais, D. Singh, Budesonide/formoterol vs. salmeterol/fluticasone in COPD: a systematic review and adjusted indirect comparison of pneumonia in randomised controlled trials. International Journal of Clinical Practice. ,vol. 65, pp. 764- 774 ,(2011) , 10.1111/J.1742-1241.2011.02685.X

M Miravitlles, J B Soriano, F Garcia-Rio, L Munoz, E Duran-Tauleria, G Sanchez, V Sobradillo, J Ancochea, Prevalence of copd in spain: impact of undiagnosed copd on quality of life and daily life activities. Thorax. ,vol. 64, pp. 863- 868 ,(2009) , 10.1136/THX.2009.115725

C. Janson, K. Larsson, K. H. Lisspers, B. Stallberg, G. Stratelis, H. Goike, L. Jorgensen, G. Johansson, Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting β2 agonist: observational matched cohort study (PATHOS) BMJ. ,vol. 346, ,(2013) , 10.1136/BMJ.F3306

Berne Eriksson, Anne Lindberg, Hana Müllerova, Eva Rönmark, Bo Lundbäck, Association of Heart Diseases With COPD and Restrictive Lung Function--Results From a Population Survey Respiratory Medicine. ,vol. 107, pp. 98- 106 ,(2013) , 10.1016/J.RMED.2012.09.011

Peter M.A. Calverley, Robert A. Stockley, Terence A.R. Seemungal, Gerry Hagan, Lisa R. Willits, John H. Riley, Jadwiga A. Wedzicha, Reported Pneumonia in Patients With COPD: Findings From the INSPIRE Study Chest. ,vol. 139, pp. 505- 512 ,(2011) , 10.1378/CHEST.09-2992

Kayleigh M Kew, Alieksei Seniukovich, Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews. ,vol. 3, ,(2014) , 10.1002/14651858.CD010115.PUB2

Helena Backman, Berne Eriksson, Eva Rönmark, Linnea Hedman, Caroline Stridsman, Sven-Arne Jansson, Anne Lindberg, Bo Lundbäck, Decreased prevalence of moderate to severe COPD over 15 years in northern Sweden. Respiratory Medicine. ,vol. 114, pp. 103- 110 ,(2016) , 10.1016/J.RMED.2016.03.013

Courtney Crim, Peter MA Calverley, Julie A Anderson, Andrew P Holmes, Sally Kilbride, Fernando J Martinez, Robert D Brook, David E Newby, Julie C Yates, Bartolomé R Celli, Jørgen Vestbo, None, Pneumonia risk with inhaled fluticasone furoate and vilanterol in COPD patients with moderate airflow limitation: The SUMMIT trial Respiratory Medicine. ,vol. 131, pp. 27- 34 ,(2017) , 10.1016/J.RMED.2017.07.060

Luis Javier Nannini, Toby J Lasserson, Phillippa Poole, Combined corticosteroid and long-acting beta2-agonist in one inhaler versus long-acting beta2-agonists for chronic obstructive pulmonary disease Cochrane Database of Systematic Reviews. ,vol. 2012, ,(2012) , 10.1002/14651858.CD006829.PUB2